EU clears first allogeneic stem cell therapy by Selina McKee | Mar 26, 2018 | News | 0 TiGenix and Takeda’s Alofisel has become the first allogeneic stem cell therapy to be approved for use across the European Union. Read More
Takeda/Tigenix’ stem cell therapy hits targets in Crohn’s trial by Selina McKee | Aug 3, 2016 | News | 0 Takeda and TiGenix’ stem cell therapy has shown promise in inducing remission of perianal fistulas in patients with Crohn’s disease, according findings of a late-stage trial published in The Lancet. Read More